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DISEASE PROGRESSION AND RECURRENT
PERIODS OF SEVERE SYMPTOMS
Borg S, Ericsson Å
AstraZeneca R&D Lund, Lund, Sweden
OBJECTIVES: To construct a health economic model 
for a chronic condition with slow irreversible disease pro-
gression (slow process) and recurrent periods of severe
symptoms (rapid process), processes which are depen-
dent. We wish to study changes to either process or both
simultaneously.
METHODS: The processes are dependent; more pro-
gressed patients have more frequent and worse attacks,
more frequent attacks lead to accelerated progress. Esti-
mating short-term transition probabilities for the slow
process is difﬁcult, suggesting a time-scale with long
cycles. However, long cycles are irrelevant for the rapid
process, thus suggesting short cycles. Denote the progress
with a discrete scale of increasing progress, 1, 2, . . . , and
attacks 0 = no attack, and 1 = ongoing attack.
RESULTS: We use a two-dimensional discrete time
Markov model, disease progression in dimension Y and
attacks in dimension X. The probability of X depends on
the previous X and Y, and vice versa for Y. Hence the
dependence between X and Y can be modeled. Costs and
outcomes are estimated using state and transition
rewards, enabling health economic analysis. Updating X
more frequently (e.g. weekly) than Y (e.g. yearly) gives
relevant cycle lengths. Y updates in outer cycles, and X
updates in inner cycles. X’s dependence on Y is straight-
forward, but Y’s dependence of X makes it necessary to
summarise outcomes in the inner cycle, to inform update
in the outer cycles. The type of summary depends on the
evaluation method, e.g. Monte Carlo simulation requires
total time in X = 0 and X = 1 to estimate the progression
risk since it depends on X.
CONCLUSIONS: Using cycle lengths relevant for each of
the processes improves transition probability estimates in
terms of predicting observed outcomes. This compensates
for increased error due to different update rates. The face
validity of the model may be improved by using relevant
cycle lengths for the processes.
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PSYCHOMETRIC PROPERTIES OF THE HEALTH
RELATED QUALITY OF LIFE INSTRUMENT IN
THE MEDICAL EXPENDITURE PANEL SURVEY
Shetty VL, Crawford SY, Conrad KJ, Lambert BL,
Woodward J
University of Illinois at Chicago, Chicago, IL, USA
Health Related Quality of Life (HRQL) is viewed as 
an important health outcomes indicator, particularly for
decision-making. Well-established high psychometric
properties of HRQL instruments are key in their selection
for research purposes.
OBJECTIVES: This study determined the psychometric
properties of the HRQL instrument used in the Medical
Expenditure Panel Survey (MEPS) and offered recom-
mendations about its use.
METHODS: The psychometric properties investigated
were reliability (internal consistency) and validity (con-
tent, construct, and known groups). Content validity was
estimated by comparison with established HRQL instru-
ments e.g. SF-36 and others. Construct validity was esti-
mated by factor analysis using the principal components
method and internal consistency was established using
Cronbach’s alpha. Known groups validity of the HRQL
scores was estimated by one-way analysis of variance
(ANOVA) and post hoc Tukey’s HSD using age groups
and perceived general health status as the independent
variables.
RESULTS: The HC-005 measures four of the most fre-
quently represented health concepts (physical function-
ing, social functioning, role functioning and health
perceptions). The factor analysis indicated that the instru-
ment measured two underlying constructs—Physical
Functioning and Activities of Daily Living (ADL). The
instrument had a high overall internal consistency (0.85).
The Physical Functioning and ADL scales had high (0.87)
and good (0.67) internal consistency respectively. The
scales scores did not show any ﬂoor and ceiling effects.
ANOVA indicated that the scales were able differentiate
between age groups and perceived general health
responses.
CONCLUSIONS: The MEPS HRQL instrument has a
reasonably good design and broad scales that capture
HRQL domains such as Physical Functioning and ADL’s.
The ﬁndings demonstrate good to average psychometric
proﬁles for this instrument. There is still further need to
establish the psychometric properties of this instrument
for health care decision making.
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EVALUATING THE USE OF PROBABILISTIC
SENSITIVITY ANALYSIS VIA MONTE CARLO
SIMULATION (MCS):AN AUDIT OF THE HEALTH
ECONOMIC LITERATURE
Botteman M, Bell C, Stephens J
Abt Associates Clinical Trials, Bethesda, MD, USA
OBJECTIVES: Probabilistic sensitivity analysis (PSA)
using MCS is one method of addressing parameter uncer-
tainty within health economic models. Although broad
recommendations (e.g., from ISPOR) exist on the appro-
priate use of these techniques, practical guidance regard-
ing their application remains limited. We surveyed the
literature to assess how PSA has been applied, how trans-
parent these methods have been, and to provide some
guidance for their future use.
METHODS: A MEDLINE search identiﬁed articles men-
tioning “PSA” or “MCS AND cost” between 1966 and
